Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 214

Cited In for PubMed (Select 20430429)

1.

Principles of Cancer Screening.

Pinsky PF.

Surg Clin North Am. 2015 Oct;95(5):953-66. doi: 10.1016/j.suc.2015.05.009. Epub 2015 Jun 20. Review.

PMID:
26315516
2.

Colorectal Adenoma - Resection Techniques and Surveillance.

Kähler G, Reinacher-Schick A.

Viszeralmedizin. 2014 Feb;30(1):8-9. doi: 10.1159/000360561. No abstract available.

3.

Beverage intake preference and bowel preparation laxative taste preference for colonoscopy.

Laiyemo AO, Burnside C, Laiyemo MA, Kwagyan J, Williams CD, Idowu KA, Ashktorab H, Kibreab A, Scott VF, Sanderson AK.

World J Gastrointest Pharmacol Ther. 2015 Aug 6;6(3):84-8. doi: 10.4292/wjgpt.v6.i3.84.

4.

Correlation of human epidermal growth factor receptor protein expression and colorectal cancer.

Yang WJ, Shen XJ, Ma XX, Tan ZG, Song Y, Guo YT, Yuan M.

World J Gastroenterol. 2015 Jul 28;21(28):8687-96. doi: 10.3748/wjg.v21.i28.8687.

5.

Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies.

Castells A.

Therap Adv Gastroenterol. 2015 Jul;8(4):221-33. doi: 10.1177/1756283X15578610. Review.

6.

Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA.

Ladabaum U, Alvarez-Osorio L, Rösch T, Brueggenjuergen B.

Endosc Int Open. 2014 Jun;2(2):E96-E104. doi: 10.1055/s-0034-1377182. Epub 2014 Jun 6.

7.

Alcohol Consumption, Depression, Insomnia and Colorectal Cancer Screening: Racial Differences.

Owusu D, Quinn M, Wang KS.

Int J High Risk Behav Addict. 2015 Jun 20;4(2):e23424. doi: 10.5812/ijhrba.4(2)2015.23424. eCollection 2015 Jun.

8.

High Rab27A expression indicates favorable prognosis in CRC.

Shi C, Yang X, Ni Y, Hou N, Xu L, Zhan F, Zhu H, Xiong L, Chen P.

Diagn Pathol. 2015 Jun 13;10:68. doi: 10.1186/s13000-015-0303-3.

9.

Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening.

Goede SL, Kuntz KM, van Ballegooijen M, Knudsen AB, Lansdorp-Vogelaar I, Tangka FK, Howard DH, Chin J, Zauber AG, Seeff LC.

Med Care. 2015 Jul;53(7):630-8. doi: 10.1097/MLR.0000000000000380.

PMID:
26067885
10.

Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples.

Thomas DS, Fourkala EO, Apostolidou S, Gunu R, Ryan A, Jacobs I, Menon U, Alderton W, Gentry-Maharaj A, Timms JF.

Br J Cancer. 2015 Jul 14;113(2):268-74. doi: 10.1038/bjc.2015.202. Epub 2015 Jun 2.

11.

Non-physician endoscopists: A systematic review.

Stephens M, Hourigan LF, Appleyard M, Ostapowicz G, Schoeman M, Desmond PV, Andrews JM, Bourke M, Hewitt D, Margolin DA, Holtmann GJ.

World J Gastroenterol. 2015 Apr 28;21(16):5056-71. doi: 10.3748/wjg.v21.i16.5056.

12.

Protective association of colonoscopy against proximal and distal colon cancer and patterns in interval cancer.

Shergill AK, Conners EE, McQuaid KR, Epstein S, Ryan JC, Shah JN, Inadomi J, Somsouk M.

Gastrointest Endosc. 2015 Sep;82(3):529-537.e1. doi: 10.1016/j.gie.2015.01.053. Epub 2015 May 1.

PMID:
25936449
13.

Gene expression profile analysis of colorectal cancer to investigate potential mechanisms using bioinformatics.

Kou Y, Zhang S, Chen X, Hu S.

Onco Targets Ther. 2015 Apr 8;8:745-52. doi: 10.2147/OTT.S78974. eCollection 2015.

14.

Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for Canada.

Coldman AJ, Phillips N, Brisson J, Flanagan W, Wolfson M, Nadeau C, Fitzgerald N, Miller AB.

Curr Oncol. 2015 Apr;22(2):e41-50. doi: 10.3747/co.22.2013.

15.

Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.

Huddy JR, Ni MZ, Markar SR, Hanna GB.

World J Gastroenterol. 2015 Apr 14;21(14):4111-20. doi: 10.3748/wjg.v21.i14.4111. Review.

16.

The prognostic significance of age in operated and non-operated colorectal cancer.

Li J, Wang Z, Yuan X, Xu L, Tong J.

BMC Cancer. 2015 Feb 25;15:83. doi: 10.1186/s12885-015-1071-x.

17.

Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials.

Tang V, Boscardin WJ, Stijacic-Cenzer I, Lee SJ.

BMJ. 2015 Apr 16;350:h1662. doi: 10.1136/bmj.h1662. Erratum in: BMJ. 2015;350:h2228.

18.

Differential expression of circulating microRNAs according to severity of colorectal neoplasia.

Ho GY, Jung HJ, Schoen RE, Wang T, Lin J, Williams Z, Weissfeld JL, Park JY, Loudig O, Suh Y.

Transl Res. 2015 Sep;166(3):225-32. doi: 10.1016/j.trsl.2015.02.004. Epub 2015 Feb 23.

PMID:
25770825
19.

The impact of screening on colorectal cancer mortality and incidence: has it really made a difference?

Zauber AG.

Dig Dis Sci. 2015 Mar;60(3):681-91. doi: 10.1007/s10620-015-3600-5. Epub 2015 Mar 5. Review.

PMID:
25740556
20.

Colorectal cancer deaths attributable to nonuse of screening in the United States.

Meester RG, Doubeni CA, Lansdorp-Vogelaar I, Goede SL, Levin TR, Quinn VP, Ballegooijen Mv, Corley DA, Zauber AG.

Ann Epidemiol. 2015 Mar;25(3):208-213.e1. doi: 10.1016/j.annepidem.2014.11.011. Epub 2014 Dec 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk